News

Targeted Oncology2h
KEYNOTE-689 Leads to FDA Approval of Perioperative Pembrolizumab in HNSCC
Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.
Medscape23h
Perioperative Pembrolizumab Approved to Up Chance of HNSCC Cure
FDA has approved perioperative pembrolizumab for resectable head and neck squamous cell carcinoma, but do patients need ...
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
Ricki Lake says she's open to talk about her plastic surgery: 'I don't want there to be any stigma'
Kylie Jenner went viral last week after revealing details about her breast augmentation in a TikTok comment.
Ricki Lake Reveals She Got a Face and Neck Lift, Calls It ‘the Best I've Ever Seen' as She Shouts Out Her Surgeon
Ricki Lake discussed her recent cosmetic procedures while on ‘Watch What Happens Live with Andy Cohen’ on Thursday, June 12.
Fierce Pharma1d
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
CURE19h
FDA Approves Perioperative Keytruda for Locally Advanced Head and Neck Cancer
Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...